Telsey Advisory Group Reiterates Outperform on Grove Collaborative Hldgs, Maintains $3 Price Target

Telsey Advisory Group analyst Dana Telsey reiterates Grove Collaborative Hldgs (NYSE:GROV) with a Outperform and maintains $3 price target.

byBenzinga Newsdesk

March 15, 2023

1 minute read

Telsey Advisory Group analyst Dana Telsey reiterates Grove Collaborative Hldgs (NYSE:GROV) with a Outperform and maintains $3 price target.

Bausch Health Investors Request Blocking Eye-Care Business Spinoff, Alleging Protection From Lawsuits

By Vandana Singh

Today, 4:23 AM

More than 50 funds that own Bausch Health Companies Inc (NYSE: BHC) investors are reportedly seeking to block the eye-care business spin-off, Bausch + Lomb Corp (NYSE: BLCO).

BHC

Recap: Willis Towers Watson Q2 Earnings

By Benzinga Insights

Today, 4:23 AM

Shares of Willis Towers Watson (NASDAQ:WLTW) remained unaffected after the company reported Q2 results. Quarterly Results Earnings per share rose 47.78% year over year to $2.66, which beat the estimate of $2.00.

WLTW

News

Apple Insights: Return On Capital Employed

By Benzinga Insights

Today, 4:23 AM

Apple (NASDAQ:AAPL) posted Q2 earnings of $27.50 billion, an increase from Q1 of 17.98%. Sales dropped to $89.58 billion, a 19.61% decrease between quarters. Apple reached earnings of $33.53 billion and sales of $111.44 billion in Q1.

AAPL

BIMI Announces 1-For-10 Reverse Stock Split

By Michael Horton

Today, 4:23 AM

BIMI International Medical Inc. (NASDAQ:BIMI) ("BIMI" or the "Company"), a healthcare products and services provider, today announced a 1-for-10 reverse split of its common stock

BIMI

Telsey Advisory Group Reiterates Outperform on Grove Collaborative Hldgs, Maintains $3 Price Target

Related Posts

Bausch Health Investors Request Blocking Eye-Care Business Spinoff, Alleging Protection From Lawsuits

Recap: Willis Towers Watson Q2 Earnings

Apple Insights: Return On Capital Employed

BIMI Announces 1-For-10 Reverse Stock Split